Literature DB >> 7715739

5-Hydroxytryptamine 5-HT1B receptors inhibiting cyclic AMP accumulation in rat renal mesangial cells.

P Schoeffter1, J Pfeilschifter, I Bobirnac.   

Abstract

A clonal cell line derived from rat renal mesangial cells was shown to express endogenous 5-hydroxytryptamine (serotonin, 5-HT) receptors that mediate inhibition of cyclic AMP accumulation. These receptors were characterized as being of the 5-HT1B receptor subtype. 5-HT1 receptor agonists inhibited forskolin-stimulated cyclic AMP accumulation in rat renal mesangial cells (60-70% maximal inhibition) with the following rank order of potency (mean pEC50 values +/- SEM, n > or = 3): ergotamine (9.58 +/- 0.51) > RU 24969 (8.67 +/- 0.23) > or = 5-CT (8.42 +/- 0.06) > or = CP 93129 (8.15 +/- 0.27) > 5-HT (7.75 +/- 0.11) > sumatriptan (6.29 +/- 0.30) > 8-OH-DPAT (4.32 +/- 0.15). 5-HT2 and 5-HT4 receptor agonists were without effect. 5-HT-induced inhibition of cyclic AMP accumulation was abolished by a pre-treatment of the cells with pertussis toxin. (-)Propranolol was a partial agonist (27% maximal inhibition, pEC50 7.19 +/- 0.24, n = 3); when used as an antagonist at 1 microM, it shifted the concentration-response curve of 5-HT to the right (pKB 7.22 +/- 0.35, n = 3). Methiothepin was a competitive antagonist of 5-HT (pA2 8.04 +/- 0.10, Schild slope 0.87 +/- 0.21, n = 3). Rauwolscine (10 microM) had no antagonist activity. There was a significant correlation (r = 0.98, P = 0.0001) between the cyclic AMP data obtained in rat mesangial cells and 5-HT1B binding data reported in rat brain cortex. The same pattern of responses was observed in early passages of primary cultures of rat mesangial cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715739     DOI: 10.1007/bf00169061

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

Review 1.  A subfamily of 5-HT1D receptor genes.

Authors:  P R Hartig; T A Branchek; R L Weinshank
Journal:  Trends Pharmacol Sci       Date:  1992-04       Impact factor: 14.819

2.  BRL 24924: a potent agonist at a non-classical 5-HT receptor positively coupled with adenylate cyclase in colliculi neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Eur J Pharmacol       Date:  1989-03-21       Impact factor: 4.432

3.  Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.

Authors:  D Hoyer; G Engel; H O Kalkman
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

4.  5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists.

Authors:  P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

Review 5.  A proposed new nomenclature for 5-HT receptors.

Authors:  P P Humphrey; P Hartig; D Hoyer
Journal:  Trends Pharmacol Sci       Date:  1993-06       Impact factor: 14.819

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization.

Authors:  D Hoyer; C Waeber; P Schoeffter; J M Palacios; A Dravid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

8.  Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.

Authors:  N Adham; B Ellerbrock; P Hartig; R L Weinshank; T Branchek
Journal:  Mol Pharmacol       Date:  1993-03       Impact factor: 4.436

9.  5-HT1B receptors mediate potent contractile responses to 5-HT in rat caudal artery.

Authors:  D A Craig; G R Martin
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

10.  3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole.

Authors:  J E Macor; C A Burkhart; J H Heym; J L Ives; L A Lebel; M E Newman; J A Nielsen; K Ryan; D W Schulz; L K Torgersen
Journal:  J Med Chem       Date:  1990-08       Impact factor: 7.446

View more
  7 in total

1.  Functional, endogenously expressed 5-hydroxytryptamine 5-ht7 receptors in human vascular smooth muscle cells.

Authors:  P Schoeffter; C Ullmer; I Bobirnac; G Gabbiani; H Lübbert
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

2.  Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters.

Authors:  C F Ferris; R H Melloni; G Koppel; K W Perry; R W Fuller; Y Delville
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

3.  Functional serotonin 5-HT1D receptors and 5-HT1D beta receptor mRNA expression in human umbilical vein endothelial cells.

Authors:  P Schoeffter; C Ullmer; M Gutierrez; G Weitz-Schmidt; H Lübbert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

4.  Effects of current and prospective antimigraine drugs on the porcine isolated meningeal artery.

Authors:  Suneet Mehrotra; Saurabh Gupta; Ingrid M Garrelds; Carlos M Villalón; Pramod R Saxena; Ad J J C Bogers; Antoinette Maassenvandenbrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-11-14       Impact factor: 3.000

5.  5-Hydroxytryptamine 5-HT1D receptors mediating inhibition of cyclic AMP accumulation in Madin-Darby canine kidney (MDCK) cells.

Authors:  P Schoeffter; I Bobirnac
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-09       Impact factor: 3.000

6.  Coupling of an endogenous 5-HT1B-like receptor to increases in intracellular calcium through a pertussis toxin-sensitive mechanism in CHO-K1 cells.

Authors:  J M Dickenson; S J Hill
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

7.  Trigeminovascular effects of propranolol in men and women, role for sex steroids.

Authors:  Eloísa Rubio-Beltrán; Rianne M Schoon; Jeffrey van den Berg; Catharina C M Schuiling-Veninga; Birgit C P Koch; Carlos M Villalón; Jorie Versmissen; A H Jan Danser; Anton H van den Meiracker; Khatera Ibrahimi; Antoinette MaassenVanDenBrink
Journal:  Ann Clin Transl Neurol       Date:  2022-08-27       Impact factor: 5.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.